URINE CHECK-ER, Wins CES 2025 Innovation Award
- 2024.11.11
DNC Biotechnology has been awarded the prestigious CES Innovation Award for its home urine diagnostic solution, ‘URINE CHECK-ER,’ marking the second consecutive year of recognition following its 2024 win.
This award, presented annually by the Consumer Technology Association (CTA), acknowledges products that exemplify exceptional technological innovation and excellence.
This year’s honor is particularly significant as it was awarded in the ‘Human Security for All’ category, a sector gaining widespread global attention. ‘URINE CHECK-ER’ is a cutting-edge home healthcare solution designed to provide unparalleled user convenience. The device allows users to conduct urine tests at home effortlessly, offering precise diagnostics, disease detection, tailored healthcare referrals, and telemedicine services. A dedicated mobile application enables instant access to test results and seamless connection with medical facilities when needed.
The solution integrates the Flexible Optical Bio Sensor technology found in the medical-grade urine chemistry analyzer ‘URINE CHECK-IT.’ This ensures that users receive clinical-grade accuracy at home, supporting swift and reliable disease diagnostics and timely follow-up care.
DNC Biotechnology’s CEO, Seongsoo Park, shared his excitement:
“We are deeply honored to receive the CES Innovation Award for the second year in a row. This recognition underscores the global value of our urine diagnostic solutions,” he said. “We remain committed to safeguarding health and improving lives through our innovative technologies.”
The revolutionary ‘URINE CHECK-ER’ will be officially unveiled at CES 2025, taking place in Las Vegas, USA, this coming January.
- Development Team’s contact info : no-reply@dncbiotech.com
- Company’s contact info : info@dncbiotech.com
- Developer’s contact info : hksong@dncbiotech.com
© 2025 D&C Biotechnology Inc. All Rights Reserved.